103 related articles for article (PubMed ID: 7478132)
1. Occult adrenal insufficiency secondary to amyloidosis in the context of chronic renal failure.
Harvey CJ; Gower PE; Hawkins PN; Pepys MB; Phillips ME
Nephrol Dial Transplant; 1995; 10(7):1237-9. PubMed ID: 7478132
[No Abstract] [Full Text] [Related]
2. [Adrenocortical insufficiency in renal amyloidosis].
Gmar-Bouraoui S; Achour A; Abbes M; Mahjoub S; Frih A; Skhiri H; Ben Dhia N; El May M
Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):4-6. PubMed ID: 11240401
[TBL] [Abstract][Full Text] [Related]
3. [Adrenal insufficiency in patients with kidney failure secondary to amyloidosis. Its detection by a stimulation test].
Fernández Lucas M; Rivera M; Teruel JL; Ortuño J
Rev Clin Esp; 1994 Aug; 194(8):613-5. PubMed ID: 7938841
[TBL] [Abstract][Full Text] [Related]
4. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
Hawkins PN; Richardson S; MacSweeney JE; King AD; Vigushin DM; Lavender JP; Pepys MB
Q J Med; 1993 Jun; 86(6):365-74. PubMed ID: 8171184
[TBL] [Abstract][Full Text] [Related]
6. [Simultaneous occurrence of dialysis-dependent renal insufficiency and generalized amyloidosis].
Hellberg OK; Vlaho M; Günther M
Med Welt; 1982 Nov; 33(47):1712-4. PubMed ID: 7176891
[No Abstract] [Full Text] [Related]
7. [The gammagraphic diagnosis of dialysis-associated amyloidosis with beta 2-microglobulin-I-131. Preliminary results].
Ponz E; Piera C; Campistol JM; Lomeña F; Pavía A; Herranz R; Muñoz Gómez J; Setoain J; Revert L
Med Clin (Barc); 1990 Oct; 95(14):538-9. PubMed ID: 2084434
[No Abstract] [Full Text] [Related]
8. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
[TBL] [Abstract][Full Text] [Related]
9. Endocrine organ failure due to systemic AA-amyloidosis.
Erdkamp FL; Gans RO; Hoorntje SJ
Neth J Med; 1991 Feb; 38(1-2):24-8. PubMed ID: 2030805
[TBL] [Abstract][Full Text] [Related]
10. Additional diagnostic value of SPECT/CT to planar Iodine-123 labeled serum amyloid P component scintigraphy in a patient with pulmonary nodular amyloidosis.
Noordzij W; Glaudemans AW; van Rheenen RW; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Jun; 21(2):131-3. PubMed ID: 24479618
[No Abstract] [Full Text] [Related]
11. Subclinical adrenocortical insufficiency in renal amyloidosis.
Arik N; Tasdemir I; Karaaslan Y; Yasavul U; Turgan C; Caglar S
Nephron; 1990; 56(3):246-8. PubMed ID: 1963924
[TBL] [Abstract][Full Text] [Related]
12. Renal transplantation for amyloid end-stage renal failure-insights from serial serum amyloid P component scintigraphy.
Gillmore JD; Madhoo S; Pepys MB; Hawkins PN
Nucl Med Commun; 2000 Aug; 21(8):735-40. PubMed ID: 11039456
[TBL] [Abstract][Full Text] [Related]
13. New frontiers in the study of amyloidosis.
Cohen AS; Skinner M
N Engl J Med; 1990 Aug; 323(8):542-3. PubMed ID: 2377179
[No Abstract] [Full Text] [Related]
14. Tissue Doppler features of cardiac amyloidosis.
Elliott PM; Mahon NG; Matsumura Y; Hawkins PN; Gillmore JD; McKenna WJ
Clin Cardiol; 2000 Sep; 23(9):701. PubMed ID: 11016022
[No Abstract] [Full Text] [Related]
15. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.
Hawkins PN; Richardson S; Vigushin DM; David J; Kelsey CR; Gray RE; Hall MA; Woo P; Lavender JP; Pepys MB
Arthritis Rheum; 1993 Jun; 36(6):842-51. PubMed ID: 8507227
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis.
Hutt DF; Gilbertson J; Quigley AM; Wechalekar AD
Amyloid; 2016 Jun; 23(2):134-5. PubMed ID: 26981883
[No Abstract] [Full Text] [Related]
17. [Mapping of amyloidosis by Iodine-123 labelled serum amyloid P component scintigraphy: myth or reality?].
Hachulla E; Deveaux M; Duquesnoy B; Marchandise X
Rev Med Interne; 1994 Apr; 15(4):238-9. PubMed ID: 8059142
[No Abstract] [Full Text] [Related]
18. Amyloid proteins in pathogenesis of AA amyloidosis.
Cunnane G
Lancet; 2001 Jul; 358(9275):4-5. PubMed ID: 11454365
[No Abstract] [Full Text] [Related]
19. Imaging amyloidosis in Still's disease.
Hawkins P; Bloom SR; Cassar J; Cox TM; Pepys MB; Waxman J
BMJ; 1989 Sep; 299(6703):848-50. PubMed ID: 2510854
[No Abstract] [Full Text] [Related]
20. Scintigraphy using iodine 123-labeled serum amyloid P component in ten patients with secondary AA type amyloidosis. A descriptive study.
Feutrie ML; Hachulla E; Flipo RM; Huglo D; Maulin L; Deveaux M; Duquesnoy B; Delcambre B; Marchandise X
Rev Rhum Engl Ed; 1996 Dec; 63(11):866-9. PubMed ID: 9010977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
